Source: Annual Congress 2003 - Airway obstruction
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. B. Bukreeva, E. A. Dementieva, S. V. Nesterovich, G. A. Suchanova, G. N. Seitova (Tomsk, Russia). Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation. Eur Respir J 2003; 22: Suppl. 45, 2680

Member's Comments

No comment yet.

Related content which might interest you: Determinants of heightened systemic inflammation at exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 115s Year: 2006 Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Investigation of the very early immune response in viral induced experimental asthma exacerbation Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Local and systemic inflammation in acute viral exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Acceleration of neutrophilic inflammation during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency Source: ERS Lung Science Conference 2021 Year: 2021 Comparison of the inflammatory response between two chronic models of allergic lung inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Impact of chronic bronchial infection on the lungs and beyond Source: Eur Respir Monogr 2013; 60: 46-57 Year: 2013